Effects of dexmedetomidine on pharyngeal swallowing and esophageal motility-A double-blind randomized cross-over study in healthy volunteers

被引:3
|
作者
Cajander, Per [1 ,7 ]
Omari, Taher [2 ]
Magnuson, Anders [3 ]
Scheinin, Harry [4 ,5 ,6 ]
Scheinin, Mika [1 ]
Savilampi, Johanna [1 ]
机构
[1] Orebro Univ, Fac Med & Hlth, Sch Med Sci, Dept Anesthesiol & Intens Care, Orebro, Sweden
[2] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia
[3] Orebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden
[4] Univ Turku, Turku PET Ctr, Turku, Finland
[5] Turku Univ Hosp, Turku, Finland
[6] Turku Univ Hosp, Dept Perioperat Serv, Intens Care & Pain Med, Turku, Finland
[7] Orebro Univ, Fac Med & Hlth, Sch Med Sci, Dept Anesthesiol & Intens Care, S-70185 Orebro, Sweden
来源
NEUROGASTROENTEROLOGY AND MOTILITY | 2023年 / 35卷 / 01期
基金
英国医学研究理事会;
关键词
dexmedetomidine; esophageal motility; pulmonary aspiration; sedatives; swallowing function; DORSAL MOTOR NUCLEUS; INCREASING PLASMA-CONCENTRATIONS; SPHINCTER PRESSURE; GASTROESOPHAGEAL-REFLUX; SEDATION; CARE; REMIFENTANIL; PROPOFOL; STIMULATION; ASPIRATION;
D O I
10.1111/nmo.14501
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundSedative agents increase the risk of pulmonary aspiration, where an intact swallowing function is an important defense mechanism. Dexmedetomidine is an alpha(2)-adrenoceptor agonist widely used during procedural sedation due to beneficial properties with minimal respiratory effects. The effects of dexmedetomidine on pharyngeal swallowing and esophageal motility are not known in detail. MethodsTo determine the effects of dexmedetomidine on pharyngeal swallowing and esophageal motility, nineteen volunteers were included in this double-blinded, randomized placebo-controlled cross-over study. Study participants received target-controlled dexmedetomidine and placebo infusions. Recordings of pressure and impedance data were acquired using a manometry and impedance solid-state catheter. Data were analyzed from three bolus swallows series: baseline, during dexmedetomidine/placebo infusion at target plasma concentrations 0.6 ng ml(-1) and 1.2 ng ml(-1). Subjective swallowing difficulties were also recorded. Key ResultsOn pharyngeal swallowing, dexmedetomidine affected the upper esophageal sphincter with decreased pre- and post-swallow contractile pressures and an increase in residual pressure during swallow-related relaxation. On esophageal function, dexmedetomidine decreased contractile vigor of the proximal esophagus and increased velocity of the peristaltic contraction wave. Residual pressures during swallow-related esophagogastric junction (EGJ) relaxation decreased, as did basal EGJ resting pressure. The effects on the functional variables were not clearly dose-dependent, but mild subjective swallowing difficulties were more common at the higher dose level. Conclusions and InferencesDexmedetomidine induces effects on pharyngeal swallowing and esophageal motility, which should be considered in clinical patient management and also when a sedative agent for procedural sedation or for manometric examination is to be chosen.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Effect of Rennie Liquid versus Maalox Liquid on intragastric pH in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers
    Hurlimann, S
    Michel, K
    Inauen, W
    Halter, F
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (06): : 1173 - 1180
  • [42] Digestive tolerance of inulin-type fructans: a double-blind, placebo-controlled, cross-over, dose-ranging, randomized study in healthy volunteers
    Bruhwyler, Jacques
    Carreer, Fabienne
    Demanet, Etienne
    Jacobs, Heidi
    [J]. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2009, 60 (02) : 165 - 175
  • [43] A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers
    Walton, Gemma E.
    Lu, Congyi
    Trogh, Isabel
    Arnaut, Filip
    Gibson, Glenn R.
    [J]. NUTRITION JOURNAL, 2012, 11
  • [44] A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers
    Gemma E Walton
    Congyi Lu
    Isabel Trogh
    Filip Arnaut
    Glenn R Gibson
    [J]. Nutrition Journal, 11
  • [45] Effects of Beef Protein Supplementation in Male Elite Triathletes: A Randomized, Controlled, Double-Blind, Cross-Over Study
    Valenzuela, Pedro L.
    Montalvo, Zigor
    Mata, Fernando
    Gonzalez, Manuela
    Larumbe-Zabala, Eneko
    Naclerio, Fernando
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2021, 40 (01) : 53 - 60
  • [46] EFFECTS OF CISAPRIDE ON CONSTIPATION IN PARAPLEGIC PATIENTS - A PLACEBO-CONTROLLED RANDOMIZED DOUBLE-BLIND CROSS-OVER STUDY
    DEBOTH, PSM
    DEGROOT, GH
    SLOOTMAN, HR
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1992, 4 (12) : 1013 - 1017
  • [47] Effects of meloxicam and rofecoxib on psychomotor performance: A randomized, double-blind, placebo-controlled cross-over study
    Al-Nimer, Marwan S. M.
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2007, 39 (06) : 291 - 293
  • [48] Task experience eliminates catecholaminergic effects on inhibitory control - A randomized, double-blind cross-over neurophysiological study
    Mueckschel, Moritz
    Roessner, Veit
    Beste, Christian
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 35 : 89 - 99
  • [49] Effects of Neurapas® balance on sleep EEG, cognitive performance and mood:: A double blind randomised cross-over study in healthy volunteers
    Giesler, M.
    Thum, A.
    Haag, A.
    Wartenberg-Demand, A.
    McGregor, G. P.
    Krieg, J. C.
    Kundermann, B.
    Hemmeter, U.
    [J]. PLANTA MEDICA, 2007, 73 (09) : 979 - 979
  • [50] CYCLANDELATE IN DIABETIC NEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSS-OVER STUDY
    HEIMANS, JJ
    DRUKARCH, B
    MATTHAEI, I
    IJFF, GA
    BERTELSMANN, FW
    STRIJERS, RLM
    NAUTA, J
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (06): : 483 - 486